Testing a Potential Therapeutic Target for Lymphoma
This study investigates a new therapeutic target (valosin-containing protein) for dogs with lymphoma.
This study investigates a new therapeutic target (valosin-containing protein) for dogs with lymphoma.
This fellowship investigates genetic lesions in canine mast cell tumors using cytogenetic and expression analysis.
This study investigates how cytogenetic changes in canine osteosarcoma affect the duration of disease-free interval when patients are treated with amputation followed by doxorubicin and non-cytotoxic suramin.
This study will provide a molecular framework for understanding the process of miR-9-driven tumor spread in canine osteosarcoma, thereby generating potential new targets for therapy to prevent or treat tumor spread in this devastating disease.
This study evaluates a new therapeutic agent designed to inhibit the survivin protein in canine lymphoma.
This study investigates the role of citrullination in canine mammary cancer and how interfering with this process might lead to more effective anticancer treatments.
This study will characterize the expression of toll-like receptors, which activate the immune system, in canine osteosarcoma cells to better determine the biological consequences associated with activating these receptors.